Cargando…

Revealing potential cardiac manifestation of ADPKD using iPS cell-derived cardiomyocytes

Detalles Bibliográficos
Autor principal:	Morizane, Ryuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413538/ https://www.ncbi.nlm.nih.gov/pubmed/30711518 http://dx.doi.org/10.1016/j.ebiom.2019.01.049

Ejemplares similares

iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021)

The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
por: Takahashi, Fuga, et al.
Publicado: (2023)

Challenging the “chromatin hypothesis” of cardiac laminopathies with LMNA mutant iPS cells
por: Mozzetta, Chiara, et al.
Publicado: (2019)

Cure of ADPKD by Selection for Spontaneous Genetic Repair Events in Pkd1-Mutated iPS Cells
por: Cheng, Li-Tao, et al.
Publicado: (2012)

Pulsatile tubular cardiac tissues fabricated by wrapping human iPS cells-derived cardiomyocyte sheets
por: Tsuruyama, Shinpei, et al.
Publicado: (2019)

Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022)

Electronic cigarette extract induced toxic effect in iPS-derived cardiomyocytes
por: Basma, Hesham, et al.
Publicado: (2020)

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration
por: Masumoto, Hidetoshi, et al.
Publicado: (2014)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Development of allogeneic iPS cell‐based therapy: from bench to bedside
por: McKenna, David H, et al.
Publicado: (2022)

Yes‐associated protein activation potentiates glycogen synthase kinase‐3 inhibitor‐induced proliferation of neonatal cardiomyocytes and iPS cell‐derived cardiomyocytes
por: Kametani, Yusuke, et al.
Publicado: (2022)

In vitro cardiac safety evaluation for repurposed COVID-19 drugs by using human iPS cell-derived cardiomyocyte with gelatin fiber scaffold
por: Saotome, Toshiki, et al.
Publicado: (2021)

Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy
por: Friedrichs, Stephanie, et al.
Publicado: (2015)

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
por: Akita, Hiraku, et al.
Publicado: (2020)

Human iPS-derived pre-epicardial cells direct cardiomyocyte aggregation expansion and organization in vitro
por: Tan, Jun Jie, et al.
Publicado: (2021)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

Wolfram Syndrome iPS Cells: The First Human Cell Model of Endoplasmic Reticulum Disease
por: Urano, Fumihiko
Publicado: (2014)

Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes
por: Kuroda, Yusuke, et al.
Publicado: (2017)

A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)
por: House, Alisha, et al.
Publicado: (2019)

Beyond iPS!
Publicado: (2012)

Inhibitory effects of class I antiarrhythmic agents on Na(+) and Ca(2+) currents of human iPS cell-derived cardiomyocytes
por: Yonemizu, Sayaka, et al.
Publicado: (2019)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

Human iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac Regeneration
por: Masumoto, Hidetoshi, et al.
Publicado: (2016)

Adrenergic Stress Protection of Human iPS Cell-Derived Cardiomyocytes by Fast K(v)7.1 Recycling
por: Piccini, Ilaria, et al.
Publicado: (2017)

Engraftment and morphological development of vascularized human iPS cell-derived 3D-cardiomyocyte tissue after xenotransplantation
por: Narita, Hirokazu, et al.
Publicado: (2017)

Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells
por: De Filippis, Lidia, et al.
Publicado: (2016)

Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes
por: Inoue, Hiroyuki, et al.
Publicado: (2022)

Defining Cardiac Dysfunction in ADPKD
por: Kuo, Ivana Y.
Publicado: (2023)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells
por: Miyoshi, Masato, et al.
Publicado: (2019)

VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes
por: Philipp, Denise, et al.
Publicado: (2021)

Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity
por: Sapp, Valerie, et al.
Publicado: (2021)

Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD
por: Narita, Ichiei
Publicado: (2020)

Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome
por: Yazawa, Masayuki, et al.
Publicado: (2011)

Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses
por: Huebsch, Nathaniel, et al.
Publicado: (2016)

Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential
por: Ishii, Tetsuya
Publicado: (2014)

Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
por: Hartfield, Elizabeth M., et al.
Publicado: (2014)

Application of iPS cell-derived macrophages to cancer therapy
por: Senju, Satoru, et al.
Publicado: (2014)

An iPS‐derived in vitro model of human atrial conduction
por: Biendarra‐Tiegs, Sherri M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ba649t8pc3u20640tjdpahbnf4